mPGES-1 inhibitors (Gesynta Pharma)

N/A

Report date: 2025/03/20 15:01:27
NME

Base Information

Drug NamemPGES-1 inhibitors (Gesynta Pharma)
Drug Alias NamemPGES-1 inhibitors (Acturum Life Science)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsPainCardiovascular DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesActurum Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesGesynta Pharma Ab
Inactive CompaniesN/A
Active IndicationsPainCardiovascular DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A